# SGLT2 Inhibition in Older Obese Adults With Pre-diabetes

> **NCT04401904** · PHASE1,PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 20 (actual)

## Conditions studied

- Aging

## Interventions

- **DRUG:** Dapagliflozin 10 mg
- **BEHAVIORAL:** Nutritional counseling

## Key facts

- **NCT ID:** NCT04401904
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-25
- **Primary completion:** 2022-09-14
- **Final completion:** 2022-09-14
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04401904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04401904, "SGLT2 Inhibition in Older Obese Adults With Pre-diabetes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04401904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*